SCHEMBL4842379

SCHEMBL4842379

COc1ccc2c(c1)C(=CC(=O)c1ccc(NC(=O)C(C)(C)C)cc1)NC(C)(C)C2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPT P10636 6/20 0.40
ALDH1A1 P00352 4/20 0.40
NPC1 O15118 4/20 0.40
CYP1A2 P05177 3/20 0.40
CYP2D6 P10635 3/20 0.40
CYP2C9 P11712 3/20 0.40
CYP2C19 P33261 3/20 0.40
HTT P42858 3/20 0.40
CYP3A4 P08684 2/20 0.40
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 2/20 0.39
GAA P10253 2/20 0.39
KMT2A Q03164 3/20 0.38
MEN1 O00255 1/20 0.38
PKM P14618 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4842373 1.00 LMNA (0.40) LMNAKDM4EMAPTALDH1A1NPC1
SCHEMBL4839189 0.91 LMNA (0.42) LMNAKDM4EMAPTALDH1A1NPC1
SCHEMBL4839175 0.91 LMNA (0.42) LMNAKDM4EMAPTALDH1A1NPC1
SCHEMBL4839999 0.91 KDM4E (0.42) LMNAKDM4EMAPTALDH1A1NPC1
SCHEMBL4839986 0.91 KDM4E (0.42) LMNAKDM4EMAPTALDH1A1NPC1
SCHEMBL4841005 0.90 MAPT (0.47) LMNAKDM4EMAPTALDH1A1NPC1
SCHEMBL4840991 0.90 MAPT (0.47) LMNAKDM4EMAPTALDH1A1NPC1
SCHEMBL4844317 0.90 KMT2A (0.43) LMNAKDM4EMAPTALDH1A1NPC1
SCHEMBL4844296 0.90 KMT2A (0.43) LMNAKDM4EMAPTALDH1A1NPC1
SCHEMBL4834848 0.89 KMT2A (0.43) LMNAKDM4EMAPTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 LMNA 3014/4885KDM4E 4466/4885MAPT 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.